To ensure this email is delivered to your inbox, please add the email
address daniel.primack@thomson.com to your address book.
If you are having trouble viewing this email, please go here.

    PE Week Wire -- Friday, December 16



Friday Feedback

The rain is falling, court warrants to eavesdrop are apparently a bygone nicety and financial journalist Rebecca lost out on a chance to be Donald Trump’s PR rep for the next year (note to self: if ever asked to run a charity fundraiser, make sure to ask attendees for funds). In other words, it’s time for Friday Feedback.

First up are a couple of comments on Amp’d Mobile, which I’ve been a bit preoccupied with this week. Lynne writes: “I agree with you that Amp’d made a big splash by partnering with MTV, but I still don’t see how their overall business plan is going to make much money. They are undercutting Sprint by selling songs at $0.99 each like I-Tunes, but that price is so low that the music margins might actually be negative. Maybe the future Amp’d user will buy their phones primarily for video, but right now people are more conditioned to buy it for music.”

Then there is R, who asks: “Since when did you start pimpin’ Amp’d?” Ever since they began paying me 1% of all venture capital calls. More seriously, I honestly believe that this company will work, in large part because it keeps answering all of my devil’s advocate questions (via actions, not words). I certainly could be wrong, but my enthusiasm is genuine. If you want me to say something negative about Amp’d, how’s this: The company’s name causes all sorts of problems for writers. Specifically, how do you refer to the possessive? Amp’d’s?

*** A bunch of people commented on the pair of $250 million co-investment program mandates given to Fisher Lynch Capital (by Oregon and Washington, respectively). The general sentiment was summed up like this email from K: “Neither Washington nor Oregon are staffed or structured to efficiently do co-investments… Now whether Fisher Lynch is the best bet is a totally different question.” So you know, I have not yet been able to speak with Fisher Lynch about its strategy, structure, etc., although Linda Lynch did email yesterday to say that such a conversation can occur early in the New Year. So stay tuned.

On the overall subject of large LPs and co-investment programs, Irwin writes: “Large LPs request and get access to co-investments, but uniformly have no infrastructure to do the due diligence or react in ‘deal time.’ Therefore, they need a co-investment manager who has authority to mine their existing portfolio of fund investments for co-investments. The co-investment manager has defined discretion to source, negotiate, and invest without having to go for specific board approval. If Board approval was required, then the delays would kill deal-flow. The manager might also have discretion to source deals that are not in the client LP’s portfolio.

Co-investments are attractive because… they can be powerful in solving the asset allocation challenge of private equity—commitments vs. invested capital. Co-investments are typically ‘free’, in that the LPs don’t have to pay management fees or carried interest on the investment. They pay the co-investment manager a fee (and maybe carry) to handle deals from start to finish. The trick is being able to react in deal time and to act in concert with the deal sponsor.”

*** Finally, Jeff writes: “I am shocked that the Dunkin' Donuts deal didn't receive more coverage in today's column given your geographic loyalties. I think the Metro's blurb was longer than yours.” Criticism deserved. To make amends, I’m speaking with Mark Nunnelly of Bain Capital later today about the deal. Please send over any questions you feel are worth asking (beyond the obvious ones). If you need guidance, take a look at what some loyal D&D denizens have posted on Boston.com.

Have a great weekend…

    Top Three



Matria Healthcare Inc. (Nasdaq: MATR) has agreed to acquire CorSolutions Medical Inc., a Rosemont, Ill.–based provider of disease management and related services to employers, health plans and government-sponsored healthcare programs. The deal is valued at $445 million in cash, and is expected to close by year-end. Bank of America has provided Matria with a fully-underwritten financing commitment to fund the acquisition. corSolutions has raised around $36 million in VC funding since its 1994 inception, from firms like HLM Venture Partners, CB Health Ventures, Affinity Capital Management. www.matria.com www.corsolutions.com

Impinj Inc., a Seattle-based a Seattle-based fabless semiconductor company focused on RFID solutions for supply chain and logistics automation, has raised $26.5 million in fourth-round funding. GF Private Equity Group led the deal, and was joined by VentureTech Alliance and return backers ARCH Venture Partners, Madrona Venture Group, Mobius Venture Capital, Polaris Venture Partners, Unilever Technology Ventures, UPS Strategic Enterprise Fund and the Viterbi Group. www.inpinj.com

Rustic Canyon Partners has helped form a new fund focused on companies serving the growing Hispanic and Asian markets in the Western U.S., with a particular emphasis on minority and women-owned business. It is being done in concert with Daniel D. Villanueva (co-founder of Univision and Bastion Capital), Gabrielle Greene (former CFO of Gluecode) and Daniel L. Villanueva (co-founder of LA pro soccer team the Galaxy). The fund is called Rustic Canyon/Fontis Partners, and has held a $70 million first close on an inaugural fund targeting $150 million. www.rusticcanyon.com

    VC Deals

Funtigo Corp., a San Francisco-based provider of online photo sharing services, has raised $2.76 million in Series A funding, according to a regulatory filing. Backers include Sierra Ventures and Catamount Ventures. www.funtigo.com

Kadrodpati Inc., a startup launched by former Microsoft and Rendition Networks exec Raghav Kher, has raised Series A funding from Draper Fisher Jurvetson. According to a regulatory filing, the company has called down around $1 million of the $2 million deal.

MobiApps Holdings Pte Ltd., a Bethesda, Md.-based provider of products for tracking and managing industrial equipment and assets, has raised $10 million in Series B funding. UOB Venture Management led the deal, and was joined by Intel Capital and return backers like Partners Group. Beacon Advisors served as placement agent. www.mobiapps.com

IPeria Inc., a Burlington, Mass.-based provider of messaging and communications software for VoIP, has raised $5 million from return backer Friedli Corporate Finance of Switzerland. The company has raised around $29 million in total VC funding since its 1997 inception. www.iperia.com

Hoana Medical Inc., a Honolulu-based medical device maker, has raised $10.2 million in Series C funding led by Global Venture Capital of Tokyo. www.hoana.com

    Buyout Deals

Albertson’s Inc. (NYSE: ABS) is close to accepting a $9.6 billion, or $26 per share, buyout offer from Cerberus Capital, Kimco Realty Corp. and Supervalu Inc., according to The Wall Street Journal. The total deal would be valued at around $16.3 billion, including assumed debt. Earlier reports said that competing bidders included KKR/Apollo/TPG and TH Lee/Bain Capital/Yucaipa Cos. www.albertsons.com

JPMorgan Chase Bank has agreed to acquire Collegiate Funding Services Inc. (Nasdaq: CFSI), a Fredericksburg, Pa.-based provider of direct-to-consumer education financing solutions. The deal is valued at approximately $663 million, and is expected to close in Q1 2006. Lightyear Capital acquired control of CFS in 2002, and remains its largest shareholder. The company went public in July 2004. www.cfsloans.com

American Capital Strategies has acquired an 85% stake in Ranpak Corp., a Concord Township, Ohio–based maker of paper-based “in-the-box” protective packaging systems and materials, from First Atlantic Capital. American Capital has invested $284 million as part of the deal, consisting of preferred and common equity and senior and junior subordinated notes. A syndicate led by GE Antares Capital is providing a senior term B loan and a revolving credit facility. www.americancapital.com

BJ’s Wholesale Club Inc. (NYSE: BJ) stock jumped nearly 9% yesterday, after a Supermarket News report that the company might receive a buyout offer from Bain Capital, KKR and Vornado Realty Trust.

Fresh Del Monte Produce Inc. (NYSE: FDP) is on the auction block for up to $1.8 billion, according to The Deal. J.P. Morgan is running the auction, with first-round bids due the week of December 21.

Kao Corp. of Japan has agreed to buy Kanebo Cosmetics Inc. for around $3.5 billion. Losing bidders included a group comprised of Ripplewood Holdings, Dawia Securities SMBC Principal Investments and another team comprised of CVC Capital and Jafco Co.

PAI Partners has received European Commission approval for its proposed buyout of Perstop, the specialty chemicals subsidiary of Industri Kapital portfolio company Sydsvenska Kemi AB.

    PE-Backed IPOs
 
Emergency Medical Services Corp., a Greenwood Village, Colo.-based provider of ambulance and outsourced emergency department staffing services, priced 8.1 million common shares at $14 per share, for an IPO take of approximately $113 million. It originally planned to sell 7.8 million 7.8 million common shares to be offered at between $15 and $17 per share. It will trade on the NYSE under ticker symbol EMS, while Banc of America Securities and JPMorgan served as lead underwriters. EMS is controlled by Onex Partners, the private equity arm of Onex Corp. www.emcare.com

Directed Electronics Inc., a Vista, Calif.-based maker of consumer-branded vehicle security and convenience systems, priced 9.375 million common shares at $16 per share (middle of $15-417 range), for an IPO take of approximately $150 million. It will trade on the Nasdaq under ticker symbol DEIX, while Goldman Sachs and JPMorgan served as lead underwriters. Significant shareholders include Trivest Partners, BancBoston Inv*stments and MassMutual. www.directed.com

AlgoRx Pharmaceuticals Inc., a Secaucus, N.J.-based drug company focused on pain management, has withdrawn its IPO registration. The move had been expected, following a September announcement that AlgoRx would merge with Corgentech Inc. (Nasdaq: CGTK). The stock-for-stock deal will result in AlgoRx shareholders owning approximately 62% of the combined company. AlgoRx has raised approximately $97 million in total VC funding from firms like InterWest Partners, JPMorgan Partners, Sofinnova Ventures, Advent International, Index Ventures and Pacific Rim Ventures. www.algorx.com www.corgentech.com

Buy.com Inc., an Aliso Viejo, Calif.-based e-commerce company, has reduced its proposed IPO offering price from between $11 and $13 per share to $8 per share. It still plans to offer around 4.17 million common shares. The company originally went public in February 2000, after receiving VC support from firms like Mobius Venture Capital, but then returned to private status after a November 2001 merger. Buy.com does not list any private equity or VC investors as significant shareholders. www.buy.com

    PE-Backed M&A
 
Vernalis PLC has completed its acquisition of Cita NeutraPharmaceuticals Inc., an Ontario, Canada-based neuro-pharmaceutical company focused on small-molecule drug candidates. The deal includes an initial payment of $29.5 million, plus milestone-based earn-outs of up to an additional $35 million in additional share or cash (Vernalis’ option). Cita had raised VC funding from groups like Canadian Medical Discoveries Fund, VenGrowth, MedInnova Partners and Neuroscience Development Inc. www.vernalis.com www.citaneuro.com

ActivBiotics Inc., a Lexington, Mass.-based developer of antibacterials for high-value chronic and infectious diseases, has agreed to acquire Metaphore Pharmaceuticals Inc., a Garwood, N.J.–based drug company focused on pain, rheumatoid arthritis and other inflammatory disorders. No financial terms were disclosed. ActivBiotitics has raised around $77 million in total VC funding since its 1996 inception, from firms like HealthCare Ventures, BioVentures Inv*stors, MDS Health Ventures, Delphi Ventures, China Development Industrial Bank, Canadian Medical Discoveries Fund, New England Partners and Vengrowth. Metaphore has raised over $83 million in VC funding since its 1998 inception, from firms like Advent Venture Partners, HealthCare Ventures, Johnson & Johnson Development Corp., MDS Health Ventures, Merrill Lynch Venture Capital and Prolog Ventures. www.activbiotics.com www.metaphore.com

    Firm & Fund News

Arsenal Capital Partners has moved its offices to 320 Park Ave., 30th Floor in New York. www.arsenalcapital.com

    Human Resources

Rutland Partners has made the following promotions: Neel Das to director of finance, Ben Slatter to investment director, Oliver Jones to investment manager and David Wingfield to investment manager. www.rutlandpartners.com

Jason Fishman, a managing director with Advent International, has stepped down as chairman of Anadys Pharmaceuticals Inc. (Nasdaq: ANDS), effective December 31. He also will resign from the board of directors, but will remain a member of the Anadys clinical and scientific advisory board. www.anadyspharma.com

Private Equity Week

This is a free service of Private Equity Week, the only industry publication that tracks and researches private equity deals for the entire venture capital market. The weekly newsletter and daily website give you in-depth news on industry trends, companies seeking investors, deals at all stages, participating firms, deal conditions, proceeds and pricing. The experienced business reporters of Private Equity Week go beyond the press releases to find the stories behind the headlines. Private Equity Week offers:
  • Informative reporting on deals at every stage
  • Commentary on important trends in private equity
  • Regional roundup of SEC filings Breakdowns of private equity funds
  • Tables of venture-backed IPOs in registration and pricing
  • Strategy and market insight on venture fund activity
  • PEW Scoreboard: a comprehensive list of the past week's venture deals
  • Private Equity People: a list of the comings and goings of private equity professionals
  • Conference Calendar: a list of upcoming private equity events
Subscribe to Private Equity Week Now!



December 16, 2005
























Interested in placing
your ad above?
Learn How



View Online Version | Subscribe | Advertising Info

Thomson Financial | 195 Broadway, 10th Floor, | New York, NY 10007

Copyright 2005 by Thomson Financial. All rights reserved.